"Die traditionsreiche Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe am Campus Innenstadt der Universität München (ehemals als I. Universitätsfrauenklinik benannte Klinik) in der Maistraße ist seit fast 100 Jahren eine angesehene Einrichtung im Zentrum von München. Die Kombination aus einer reichen Tradition in Patientinnenfürsorge, dem einzigartigen baulichen Rahmen und die stetige Entwicklung hin zu moderner Wissenschaft und Medizin prägt den besonderen Geist der Frauenklinik in der Maistraße, der Patientinnen, Mitarbeiterinnen und Mitarbeitern gleichsam immer wieder aufs Neue bewusst wird."

During the past decade, Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "GOG Foundation" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde" are "Breast Cancer" (7 trials), "Ovarian Cancer" (3 trials), "Carcinosarcoma" (1 trials), "Epithelial Ovarian Cancer" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde" in a lesser frequency.

Most popular intervention types in "Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde" are "Drug" (17 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (7 trials), "Atezolizumab" (5 trials), "Cyclophosphamide" (5 trials), "Placebo" (5 trials) and "Trastuzumab Emtansine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde" are 11 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum der Universität München; Campus Großhadern; Klinik und Poliklinik für Frauenheilkunde, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".